Antisense oligonucleotides and RNAs as modulators of pre-mRNA splicing

This publication has 16 references indexed in Scilit:

• Restoration of ß-Globin Gene Expression in Mammalian Cells by Antisense Oligonucleotides That Modify the Aberrant Splicing Patierns of Thalassemic Pre-mRNAs
  Nucleosides and Nucleotides, 1997
• Antisense oligonucleotides: towards clinical trials
  Trends in Biotechnology, 1996
• Progress in Antisense Oligonucleotide Therapeutics
  Annual Review of Pharmacology and Toxicology, 1996
• Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.
  Journal of Clinical Oncology, 1996
• Antisense Oligodeoxynucleotides Directed against the Na‐Ca Exchanger mRNA
  Annals of the New York Academy of Sciences, 1996
• New Drugs: Antisense Oligodeoxynucleotides as Clinical Therapeutic Agents
  Cancer Investigation, 1996
• Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology
  Trends in Pharmacological Sciences, 1995
• In vivo stability, disposition and metabolism of a “hybrid” oligonucleotide phosphorothioate in rats
  Biochemical Pharmacology, 1995
• Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects*
  Clinical Pharmacology & Therapeutics, 1995
• RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds
  Nucleic Acids Research, 1989